share_log

Transphorm Analyst Ratings

トランスフォームアナリストレーティング

Benzinga ·  2023/08/15 09:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/15/2023 185.15% Benchmark → $8 Reiterates Buy → Buy
06/28/2023 60.4% B. Riley Securities $5.5 → $4.5 Maintains Neutral
08/16/2022 185.15% Benchmark $11 → $8 Maintains Buy
06/15/2022 131.69% B. Riley Securities $9 → $6.5 Downgrades Buy → Neutral
05/25/2022 220.8% B. Riley Securities $10 → $9 Maintains Buy
07/27/2021 292.09% Benchmark → $11 Initiates Coverage On → Buy
05/27/2021 256.44% Loop Capital → $10 Initiates Coverage On → Buy
08/28/2020 185.15% Craig-Hallum → $8 Initiates Coverage On → Buy

What is the target price for Transphorm (TGAN)?

The latest price target for Transphorm (NASDAQ: TGAN) was reported by Benchmark on August 15, 2023. The analyst firm set a price target for $8.00 expecting TGAN to rise to within 12 months (a possible 185.15% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Transphorm (TGAN)?

The latest analyst rating for Transphorm (NASDAQ: TGAN) was provided by Benchmark, and Transphorm reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Transphorm (TGAN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Transphorm, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Transphorm was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Is the Analyst Rating Transphorm (TGAN) correct?

While ratings are subjective and will change, the latest Transphorm (TGAN) rating was a reiterated with a price target of $0.00 to $8.00. The current price Transphorm (TGAN) is trading at is $2.81, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする